Antiepileptic drug discovery: Does mechanism of action matter?

Epilepsy and Behavior

Volumn 21, Issue 4, 2011, Pages 342-343

  Schmidt, Dieter ^a  

^a Epilepsy Research Group   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PLACEBO; PROGABIDE; TIAGABINE; VIGABATRIN;

ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; CLINICAL TRIAL (TOPIC); DEPRESSION; DISEASE FREE SURVIVAL; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; EPILEPSY; EVIDENCE BASED MEDICINE; HUMAN; LIVER TOXICITY; NOTE; SEIZURE; SYMPTOM; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 79961212342     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.03.037     Document Type: Note

References (12)

1. Löscher W., Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?. Epilepsy Res 1994, 17:95-134.
2. Rundfeldt C., Netzer R. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. Neurosci Lett 2000, 282:73-76.
3. Wuttke T.V., Seebohm G., Bail S., Maljevic S., Lerche H. The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol 2005, 67:1009-1017.
4. Errington A.C., Stöhr T., Heers C., Lees G. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 2008, 73:157-169.
5. Stephen L.J., Brodie M.J. Pharmacotherapy of epilepsy: newly approved and developmental agents. CNS Drugs 2011, 25:89-107.
6. Brodie MJ, Covanis A, Gil-Nagel A, et al. Antiepileptic drug therapy: does mechanism of action matter? Epilepsy Behav in press.
7. Beyenburg S., Stavem K., Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia 2010, 51:7-26.
8. Löscher W., Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 2011, 52:657-678.
9. Elger C.E., Schmidt D. Modern management of epilepsy: a practical approach. Epilepsy Behav 2008, 12:501-539.
10. Rogawski M.A., Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 2004, 10:685-692.
11. Schmidt D., Löscher W. New developments in antiepileptic drug resistance: an integrative view. Epilepsy Curr 2009, 9:47-52.
12. Temkin N.R. Preventing and treating posttraumatic seizures: the human experience. Epilepsia 2009, 50(Suppl. 2):10-13.